| Patents for C07C 233 - Carboxylic acid amides (28,881) |
|---|
| 01/29/2003 | EP1278885A1 Resolution of aminotetralins |
| 01/29/2003 | EP1278784A2 Catalysts containing n-pyrrolyl substituted nitrogen donors |
| 01/29/2003 | EP1278718A1 Novel amino acid derivatives, preparation method, compositions containing same and uses thereof as sunscreens |
| 01/29/2003 | EP1278716A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists |
| 01/29/2003 | EP0832081B1 Bicyclic-aromatic compounds |
| 01/29/2003 | EP0754175B1 Alkoxy-alkyl-substituted 1-h-3-aryl-pyrrolidine-2,4-diones used as herbicides and pesticides |
| 01/28/2003 | US6512140 Cyclization, iminoesterification, hydrolysis, in situ oxidation, sulfiding, cleavage, and purification |
| 01/28/2003 | US6512093 said fatty acids being chlorinated fatty acids of the olive oil. |
| 01/28/2003 | US6511990 Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 01/28/2003 | US6511988 Prevention binding of transcription factor tozinc finger binding compounds |
| 01/28/2003 | US6511980 For therapy of gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel disorder |
| 01/23/2003 | WO2003006628A2 Nad synthetase inhibitors and uses thereof |
| 01/23/2003 | WO2003006443A2 2- 4-(naphtalin-2-yl)-thiazol-2-ylaminocarbonyl benzoic acid and 2- 4-(naphtalin-2-yl)-pyrimidin-2-ylaminocarbonyl benzoic acid and additional compounds serving as telomerase inhibitors for use in tumor therapy |
| 01/23/2003 | WO2003006425A2 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 01/23/2003 | WO2003006424A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 01/23/2003 | WO2003006423A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | WO2003006422A1 New derivatives of substituted anilines with herbicidal activity |
| 01/23/2003 | WO2003006421A1 Method for purifying n2-(1(s)-ethoxycarbonyl-3- phenylpropyl)-n6-trifluoroacetyl-l-lysine |
| 01/23/2003 | WO2003005973A1 Dental self-etching primer |
| 01/23/2003 | WO2003005965A2 Modulators of ceramidase and methods of use based thereon |
| 01/23/2003 | WO2001098245A3 Triphenyl compounds as interleukin-4 antagonists |
| 01/23/2003 | WO2001070669A3 Process for forming an amide bond |
| 01/23/2003 | US20030018207 Pharmaceutical medication associated with insulin resistance; patient with prophylaxis conditions having reduced sensitivity to insulin |
| 01/23/2003 | US20030018203 2-hydroxy-3-aryls or heteroaryls-2-yl-1,1-dimethyl-ethylamino)-propoxy)-phenyl derivatives useful for treating bone or mineral disease such as osteosarcoma, periodontal disease, osteoporosis, paget's disease |
| 01/23/2003 | US20030018190 Valency platform molecules comprising carbamate linkages |
| 01/23/2003 | US20030018080 N-methoxymethyl-5,5-diphenylbarbituric acid |
| 01/23/2003 | US20030018055 Serine carbonates |
| 01/23/2003 | CA2453503A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | CA2452491A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 01/23/2003 | CA2422349A1 Process for purifying n2-(1(s)-ethoxycarbonyl-3-phenylpropyl)-n6-trifluoroacetyl-l-lysine |
| 01/22/2003 | EP1277751A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1277749A1 2- and 2,5-substituted phenylketo enols |
| 01/22/2003 | EP1277735A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1277734A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1277733A1 2- and 2,5-substituted phenylketo-enols |
| 01/22/2003 | EP1277729A1 Ppar (gamma) modulators |
| 01/22/2003 | EP1277728A1 Novel TTDA derivatives and their use as gadolinium chelators for MRI imaging |
| 01/22/2003 | EP1277726A1 Process for the preparation of 2-halobenzoic acids |
| 01/22/2003 | EP1276741A1 Phenyl substituted 4-hydroxy tetrahydropyridone |
| 01/22/2003 | EP1276716A2 Metal chelating compositions |
| 01/22/2003 | EP1276712A2 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof |
| 01/22/2003 | EP0910660B1 Process for producing optically active amines |
| 01/21/2003 | US6509491 Aminohydroxylation of olefins in the presence of acetamide |
| 01/21/2003 | US6509378 Acetamidobenzamide compounds for neurodegenerative disorders |
| 01/21/2003 | US6509369 Triphenylpropanamide compounds; useful in treating inflammations but which do not demonstrate side effects associated with other anti-inflammatory treatments such as glucocorticoids |
| 01/21/2003 | US6508753 Chiral ligands for asymmetric catalysis |
| 01/21/2003 | CA2109818C Process for preparing sertraline intermediates |
| 01/16/2003 | WO2003005025A1 Methods for identifying compounds modulating the activity of ppar-gamma |
| 01/16/2003 | WO2003004472A1 Arylamines for the treatment of conditions associated with gsk-3 |
| 01/16/2003 | WO2003004460A2 Succinic acid derivatives |
| 01/16/2003 | WO2003004458A1 New compounds |
| 01/16/2003 | WO2003004446A1 Process for producing fluorinated alcohol |
| 01/16/2003 | WO2003003987A2 Solid phase synthesis of arylretinamides |
| 01/16/2003 | US20030013762 6-methoxy-2-naphthylacetic acid prodrugs |
| 01/16/2003 | US20030013725 Amino acid derivatives |
| 01/16/2003 | US20030013719 Ortho, meta-substituted bisaryl compounds, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
| 01/16/2003 | US20030013704 Adamantane derivatives |
| 01/16/2003 | US20030013677 Anticancer agents |
| 01/16/2003 | US20030012817 Modified amino acids and derivatives can form non-covalent mixtures with active biological agents and in an alternate embodiment can releasably carry active agents. Modified amino acids can also form drug containing microspheres. |
| 01/16/2003 | US20030012763 Mixture containing the ammonium quat in a solvent that includes at least one glycol and at least one fatty alcohol, wherein said raw material composition has cationic activity of over 35%; improved transportation efficiency |
| 01/16/2003 | CA2452686A1 Arylamines for the treatment of conditions associated with gsk-3 |
| 01/15/2003 | EP1275636A1 Process for preparing methacrylamide sulfate and device to carry out the process |
| 01/15/2003 | EP1275389A1 Compositions containing C7 Taxanes |
| 01/15/2003 | EP1274686A1 Process for preparing 2-(4-chlorobenzolamino) -3- 2(1h) -quinolinon-4-yl]proprionic acid |
| 01/15/2003 | EP1274675A1 Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 01/15/2003 | EP1274353A1 A container assembly for fertilization and culture and embryo transfer and method of fertilization and culture employing such a container |
| 01/15/2003 | EP0729468B1 Non-peptide tachykinin receptor antagonists |
| 01/15/2003 | CN1098844C Substituted biphenyloxazolines |
| 01/14/2003 | US6506939 Producing N-substituted acrylamides and tertiary amines |
| 01/14/2003 | US6506797 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (PPAR) α |
| 01/14/2003 | US6506733 Compounds and compositions as protease inhibitors |
| 01/14/2003 | US6506701 Polymer-supported quenching reagent covalently reacts with unreacted starting materials |
| 01/09/2003 | WO2003002545A1 Peptoid compounds |
| 01/09/2003 | WO2003002519A1 Phenol derivatives and their use in medicaments |
| 01/09/2003 | WO2003002517A1 Process for the preparation of 1.1-cyclohexane diacetic acid monoamide |
| 01/09/2003 | WO2003002489A2 Solid-phase electrophilic fluorination |
| 01/09/2003 | WO2002059081A3 Urea derivatives as inhibitors of ccr-3 receptor |
| 01/09/2003 | US20030009039 Reacting a beta -lactam with an alkoxide to form substituted isoserine ester compound |
| 01/09/2003 | US20030008915 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
| 01/09/2003 | US20030008900 Compounds and compositions for delivering active agents |
| 01/09/2003 | US20030008889 Aminoadamantane derivatives as therapeutic agents |
| 01/09/2003 | US20030008881 Substituted phenylcyclohexanecarboxamides and their use |
| 01/09/2003 | US20030008360 Microorganisms for use in the generation of preferential cyclopentene |
| 01/09/2003 | US20030008320 Isolation of nucleic acids |
| 01/08/2003 | EP1273567A2 Betaine esters |
| 01/08/2003 | EP1272147A1 Dental materials with extendable work time, kits, and methods |
| 01/08/2003 | EP1272057A1 Sweeteners, particularly for coffee and tea |
| 01/08/2003 | EP1124833B1 Diphosphines |
| 01/08/2003 | EP1123276B1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 01/08/2003 | EP0978506B1 2-phenoxyaniline derivatives |
| 01/08/2003 | EP0866056B1 N- (fluoroalkoxy)phenoxyalkyl]benzamide compounds, intermediates thereof, process for producing the same, and agricultural and horticultural pesticides |
| 01/08/2003 | CN1390196A Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 01/08/2003 | CN1390193A Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 01/08/2003 | CN1390191A Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
| 01/08/2003 | CN1389455A Prepn. of acenaphthene derived single chiral compound |
| 01/08/2003 | CN1098278C Cinnamic acid derivative |
| 01/07/2003 | US6504058 Fungicidal amides |
| 01/07/2003 | US6504047 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof |
| 01/07/2003 | US6504046 Process for the preparation of amides |
| 01/07/2003 | US6504036 2- and 2.5-substituted phenylketoenols |